Medical Device News Magazine

Tunnel Vision Reports: Innovative Goggles to Help Individuals with Autism, ADD, & ADHD Officially Launches a Crowdfunding Campaign and Have Seen Great Results

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Tunnel Vision has announced the launch of their crowdfunding campaign that reduces stimming in individuals with autism, ADD, and ADHD through their patented Tunnel Vision Goggles.

Some individuals have debilitating and severe “stimming” behaviors which cause major distractions in the home, classroom, or therapy settings. Tunnel Vision helps by blocking over 70% of visual distractions, helping increase focus which leads to higher learning and the development of important life skills.

Jerry Perez, owner and operator of Catching Up, a behavioral center in Miami, FL, spent over 10 years creating Tunnel Vision Goggles to not only help special needs individuals improve focus, but create a deeper connection with their loved ones. Tunnel Vision also comes with a free app, complete with training videos and a community forum to help support parents and guardians who might not have the resources or access to therapy centers where they live to provide the much-needed care.

“As a special needs parent, I was frustrated with the limited options available and was tired of parents (and myself) spending their hard-earned money on gimmicks or bandages for their child”, Perez says. “My desire is to help parents connect with their children in a deeper way while providing hope for their future. In 2020, therapy centers shut down with the world, showing us the desperate need to provide a tool that parents can use in their homes. We are finally at a place to launch our crowdfunding as the last step to get Tunnel Vision Goggles worldwide. Would you help us?”

There is a wide range of “stimming” behaviors. Some are very subtle and individuals have learned to live with it, even using stimming to help them focus, i.e., playing with one’s hair. But many have a hard time controlling it causing poor eye contact, difficulty following directions, low reading/writing skills, coordination problems, and sensory issues. These types of developmental delays will make it hard for the individual in the future. Tunnel Vision solves these problems by “making their world smaller”, allowing users to focus on the task at hand.

Parents are seeing huge differences in their loved ones in as little as two months of training. One parent even said on a video,

“His teachers have seen a huge increase in eye contact and because of the strong eye contact, his language has also increased. I dare you to try it and I guarantee you will see results.”

Tunnel Vision Goggles have been tested for over 5 years in multiple countries like Panama, Brazil, Mexico, Jamaica, and Columbia, with multiple age ranges. Cumevi Therapy Center of Mexico has been using Tunnel Vision for years with teenagers. These goggles are made from durable, lightweight plastic with ultra-soft foam for maximum comfort. They are also equipped with high-quality elastic Velcro for an easy, one-size-fits-all adjustment. With 100% US manufacturing, users receive a dependable goggle that provides numerous hours of training and enjoyment.

Therapists have also found Tunnel Vision Goggles to be helpful in a clinical setting. Jillian, the owner of Whole Steps Creative Arts Center in Miami, Florida, says,

“Kids in our regular music therapy sessions have shown great improvement in their ability to focus on the task at hand. We are believers in Tunnel Vision.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”